Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized Controlled Study of Primary Prevention of Esophageal Variceal Bleeding in Cirrhotic Patients Treated With HVPG-guided Beta- Blocker Therapy or Standard Heart Rate-guided Beta-blocker Therapy

NCT01618890 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT01618890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized Controlled Study of Primary Prevention of Esophageal Variceal Bleeding in Cirrhotic Patients Treated With HVPG-guided Beta- Blocker Therapy or Standard Heart Rate-guided Beta-blocker Therapy
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2012
Completion date
December 31, 2022
Enrollment
78 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute bleeding esophageal varices, liver cirrhosis